Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by mercedesmanon Apr 01, 2024 10:55pm
141 Views
Post# 35964195

RE:TODAY’S NUMBERS

RE:TODAY’S NUMBERS

Right u r Rev 

Spectral has spent probably $150M on trials over 15 years to try to solve the unsolvable. But it's not looking so unsolvable now... at least to the medical community paying attention, and the insiders, and to the very few that follow it. 

It's just a matter of time now. 


MM

PS Simply Wallstreet uses a unique variation of AI to write their articles.  I believe it's called Artificial Imbecility. 

<< Previous
Bullboard Posts
Next >>